Stealth BioTherapeutics Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Newton MA United States (2006)

Organization Overview

First Clinical Trial
2010
NCT01115920
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Stealth BioTherapeutics | Stealth BioTherapeutics Inc. | Stealth Peptides